All Spin-out articles – Page 2
-
Business
Talk of a $6.6bn deal for Elan
Potential offer from Royalty Pharma comes as Elan ponders how to spend its cash from Tysabri rights
-
Business
Zoetis IPO launches at $2.2bn
Pfizer spin off will be a big player among a relatively small number of public companies focusing on animal heatlh
-
Business
Elan spins off drug discovery
The new company will be called Neotope Biosciences and focus on chronic degenerative diseases
-
Business
Pfizer to spin off animal health business
New company Zoetis should start independent trading by July 2013
- Previous Page
- Page1
- Page2
- Next Page